Literature DB >> 24119236

Nutrition and nutraceutical supplements for the treatment of hypertension: part II.

Mark Houston1.   

Abstract

Vascular biology, endothelial and vascular smooth muscle, and cardiac dysfunction play a primary role in the initiation and perpetuation of hypertension, cardiovascular disease, and target organ damage. Nutrient-gene interactions and epigenetics are predominant factors in promoting beneficial or detrimental effects in cardiovascular health and hypertension. Macronutrients and micronutrients can prevent, control, and treat hypertension through numerous mechanisms related to vascular biology. Oxidative stress, inflammation, and autoimmune dysfunction initiate and propagate hypertension and cardiovascular disease. There is a role for the select use of single and component nutraceutical supplements, vitamins, antioxidants, and minerals in the treatment of hypertension based on scientifically controlled studies, which complement optimal nutrition, coupled with other lifestyle modifications. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24119236      PMCID: PMC8033944          DOI: 10.1111/jch.12212

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  77 in total

1.  Magnesium for cardiovascular health: time for intervention.

Authors:  Yiqing Song; Simin Liu
Journal:  Am J Clin Nutr       Date:  2012-01-04       Impact factor: 7.045

2.  Acute combined effects of olive oil and wine on pressure wave reflections: another beneficial influence of the Mediterranean diet antioxidants?

Authors:  Christos M Papamichael; Kalliopi N Karatzi; Theodore G Papaioannou; Emmanouil N Karatzis; Paraskevi Katsichti; Vasilis Sideris; Nikolaos Zakopoulos; Antonis Zampelas; John P Lekakis
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

Review 3.  Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension.

Authors:  P Laurant; R M Touyz
Journal:  J Hypertens       Date:  2000-09       Impact factor: 4.844

Review 4.  Clinical practice. Vitamin D insufficiency.

Authors:  Clifford J Rosen
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

5.  Vitamin D and arterial hypertension: treat the deficiency!

Authors:  Katharina Kienreich; Andreas Tomaschitz; Nicolas Verheyen; Thomas R Pieber; Stefan Pilz
Journal:  Am J Hypertens       Date:  2012-12-27       Impact factor: 2.689

Review 6.  Vitamin E and adiponectin: proposed mechanism for vitamin E-induced improvement in insulin sensitivity.

Authors:  Brianna Gray; Jennifer Swick; Alayne G Ronnenberg
Journal:  Nutr Rev       Date:  2011-03       Impact factor: 7.110

7.  Plasma nitrate and nitrite are increased by a high-nitrate supplement but not by high-nitrate foods in older adults.

Authors:  Gary D Miller; Anthony P Marsh; Robin W Dove; Daniel Beavers; Tennille Presley; Christine Helms; Erika Bechtold; S Bruce King; Daniel Kim-Shapiro
Journal:  Nutr Res       Date:  2012-03       Impact factor: 3.315

Review 8.  Systematic review: Vitamin D and cardiometabolic outcomes.

Authors:  Anastassios G Pittas; Mei Chung; Thomas Trikalinos; Joanna Mitri; Michael Brendel; Kamal Patel; Alice H Lichtenstein; Joseph Lau; Ethan M Balk
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

9.  Inverse relation of dietary protein markers with blood pressure. Findings for 10,020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure.

Authors:  J Stamler; P Elliott; H Kesteloot; R Nichols; G Claeys; A R Dyer; R Stamler
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

Review 10.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  1 in total

Review 1.  Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.

Authors:  Sunil K Panchal; Stephen Wanyonyi; Lindsay Brown
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.